Neuroendocrine abnormalities in Parkinson's disease

Area of Science:

• Neuroendocrinology
• Neurology
• Metabolic Medicine

Background:

• Neuroendocrine abnormalities are prevalent in Parkinson's disease (PD).
• These include disruptions in melatonin secretion, glucose metabolism, insulin resistance, bone metabolism, and body weight.
• These abnormalities are linked to non-motor symptoms and have significant clinical implications.

Purpose of the Study:

• To review clinically relevant neuroendocrine abnormalities in Parkinson's disease.
• To highlight their role in the overall PD phenotype.
• To discuss potential therapeutic and biomarker targets.

Main Methods:

• Systems-based review of current evidence.
• Discussion of pathophysiological mechanisms.
• Analysis of clinical implications and interventions.

Main Results:

• Neuroendocrine dysfunction is a key feature of Parkinson's disease.
• Mechanisms underlying these abnormalities may be involved in PD pathogenesis.
• These offer promising targets for disease biomarkers and neuroprotective strategies.

Conclusions:

• Neuroendocrine abnormalities significantly impact the Parkinson's disease phenotype.
• Further research into these mechanisms can guide the development of novel therapies.
• Targeting neuroendocrine pathways presents opportunities for neuroprotection in PD.